Table 2 Pathways significantly affected in the CR patients
From: Early changes in gene expression profiles in AML patients during induction chemotherapy
Pathway | 24 h vs baseline | 48 h vs 24 h | 48 h vs baseline |
|---|---|---|---|
Purine Nucleotides De Novo Biosynthesis II | – | Inhibited | Inhibited |
tRNA Charging | – | Inhibited | Inhibited |
Oxidative Phosphorylation | Activated | – | Activated |
Cyclins and Cell Cycle Regulation | – | – | Inhibited |